1-8 of 8
Menaka Bhor, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

How Does Sickle Cell Disease Severity Affect Patient Collection of Disability Insurance and Income: An Analysis of US Survey Data

Jason Shafrin, Howard Z. Thom, Daisy Gaunt, Lauren M. Zhao, George J Joseph, Menaka Bhor, PhD, Avery A. Rizio, Lanetta Bronté-Hall, MPH, MSPH, MD, Nirmish Shah
Journal: Blood
Blood (2019) 134 (Supplement_1): 5781.
https://doi.org/10.1182/blood-2019-122774
Published: 2019
Journal Articles

Vaso-Occlusive Crises and Costs of Sickle Cell Disease from a Commercial Payer's Perspective

George J Joseph, Dominick Latremouille-Viau, Vikash Kumar Sharma, Patrick Gagnon-Sanschagrin, Menaka Bhor, PhD, Ankur Khare, Mukesh Kumar Singh, Elizabeth Serra, Mikhail Davidson, Annie Guerin, Nirmish Shah
Journal: Blood
Blood (2019) 134 (Supplement_1): 3464.
https://doi.org/10.1182/blood-2019-124920
Published: 2019
Journal Articles

A Systematic Literature Review of the Burden of Ischemic Priapism in Patients with Sickle Cell Disease

Dave Nellesen, PhD, Sedge Lucas, BA, Che-Rung Liu, MA., Menaka Bhor, PhD, Jincy Paulose, MD, Arthur Burnett, MD MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 3467.
https://doi.org/10.1182/blood-2019-128951
Published: 2019
Journal Articles

Relationship between Vaso-Occlusive Crisis and Quality of Life: An Analysis of Patients with Sickle Cell Disease in the United States

Howard Z. Thom, Jason Shafrin, Edna Keeney, Lauren M. Zhao, George J Joseph, Menaka Bhor, PhD, Avery A. Rizio, Lanetta Bronté-Hall, MPH, MSPH, MD, Nirmish Shah
Journal: Blood
Blood (2019) 134 (Supplement_1): 4700.
https://doi.org/10.1182/blood-2019-124132
Published: 2019
Journal Articles

Benefit-Risk Comparison in Patients with Immune Thrombocytopenia (ITP) Receiving Eltrombopag or Romiplostim: Real World Evidence (RWE) from 26 Hospital Institutions

Anna Forsythe, PharmD, MSc, MBA, Anuja Roy, PhD, Menaka Bhor, PhD, Alex Allepuz, MD MPH, Maria Do Socorro Oliveira Portella, MD MBA, Christina Kwon, BSc, MSc, PhD, Gabriel Tremblay, DBA, MSc, BS
Journal: Blood
Blood (2017) 130 (Supplement 1): 3409.
https://doi.org/10.1182/blood.V130.Suppl_1.3409.3409
Published: 2017
Journal Articles

Cost-Consequence Model Comparing Eltrombopag and Romiplostim for Pediatric Patients with Previously-Treated Chronic Immune Thrombocytopenia

Gabriel Tremblay, DBA, MSc, BS, Menaka Bhor, PhD, Anuja Roy, PhD, Brian Elliott, MD, Mike Dolph, MSc BHSc, Anna Forsythe, PharmD, MSc, MBA, Andrew Briggs, DPhil
Journal: Blood
Blood (2017) 130 (Supplement 1): 2146.
https://doi.org/10.1182/blood.V130.Suppl_1.2146.2146
Published: 2017
Journal Articles

A Systematic Literature Review of Patient-Reported Outcome Instruments Used in Sickle Cell Disease

Grammati Sarri, PhD, Menaka Bhor, PhD, Seye Abogunrin, MB BS, MPH, MSc, Caroline Farmer, PhD, Savita Nandal, MBBS, MD, Dennis A. Revicki, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4648.
https://doi.org/10.1182/blood.V130.Suppl_1.4648.4648
Published: 2017
Journal Articles

Association Between Treatment Adherence and Response Among Patients With Chronic Myeloid Leukemia (CML) Receiving First-Line TKIs In The Community Setting

Nicholas J. Di Bella, MD, Debajyoti Bhowmik, PhD, Menaka Bhor, PhD, Mark Yap, BSN, RN, Brooke Middlebrook, Debra Rembert, RN, MSN, NP, Rahul Dhanda, PhD, Zachary Cain, PharmD, Tony Okoro, PharmD, Bjorn Bolinder, MBA, Elias J. Jabbour, MD
Journal: Blood
Blood (2013) 122 (21): 2733.
https://doi.org/10.1182/blood.V122.21.2733.2733
Published: 2013